Rating: HOLD
HOLD (5-tier) · mature cash generator · conviction: medium
| Metric | Value |
|---|---|
| Current Price | $117 |
| Triangulated Fair Value | $96 (-18% vs spot · triangulated FV) |
| 12-mo Scenario PWEV | $112 (-5% vs spot · 12m PWEV) |
| Forward P/E | 12.6x |
| Market Cap | $24B |
| 52-Week Range | $89–$115 |
EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).
Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-06-27. Each chart below sits with the part of the thesis it evidences.
General research for a skeptical institutional reader. Not personalised investment advice; no position sizing or trade instructions. Figures as of the analysis date; verify before acting.
Investment Committee Summary
| Rating | HOLD · HOLD (5-tier) |
| Classification · conviction | mature cash generator · medium |
| Triangulated fair value | $96 (-18% vs spot · triangulated FV) |
| 12-mo scenario PWEV | $112 (-5% vs spot · 12m PWEV) |
| Next catalyst | 2026-02-10 — FY results & CNA special-dividend declaration |
| Primary thesis-break | CNA net combined ratio > 99.0 (2 consecutive prints) |
📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.
Rating Bridge
Rating = HOLD because:
- Probability-weighted scenario value implies -5% vs spot
- Monte Carlo median implies -16% vs spot
- DCF fair value implies -26% vs spot
- Bear case (Structural — Underwriting / Reserve / Catastrophe Reset) downside is -56% vs spot
- Net: reward/risk of 0.3× is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.
Investment Thesis
At $113.21 the shares trade near a forward multiple of about 12 and roughly at book value of $90.9 grossed for retained earnings, which implies the market prices Loews for mid-cycle CNA underwriting with little credit for the holding-company optionality. Our engine reaches a probability-weighted target of $111.36, a shade below spot, because the mid-cycle base at a $115.57 target carries only a 0.35 probability and is bracketed by a 0.20 structural-reset path at $49 and a 0.17 soft-market path near $83. The triangulation leans on the peer read: the EV/revenue-median anchor sits at $109 and the forward-P/E median at $91, both at or below spot. That balance yields a HOLD, not a buy: the discount is real but so is the cyclical and reserve risk. The single most damaging risk is adverse prior-year reserve development at CNA, which would lift the combined ratio and compress the multiple at the same time, driving the structural path.
The dashboard below is the whole argument on one page: spot ($117) against each valuation anchor, the scenario tree, technicals and the options-implied move.
Anti-Thesis (The Real Bear Case)
The highest-probability bear mechanism is the structural reset at a 0.20 weight. CNA writes long-tail commercial casualty, where loss-cost inflation and social inflation can render prior reserves inadequate years after the policy was priced. If development turns unfavourable, the combined ratio moves above 100, favourable releases that have flattered recent earnings reverse, and float income at prevailing yields cannot offset the underwriting loss. The market then re-rates the holding company from roughly 12 times toward a distressed 9.5 times on lower earnings, taking the target below the 52-week low of $89.11 to about $49. Book value per share erodes with the reserve top-up, removing the valuation floor that the current price leans on.
Key Debate
Gross Margin explains 60% of Monte Carlo outcome variance — the single variable that decides which side is right.
Earnings-Call Disconfirmation & Sentiment
Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.
Management vs analyst tone (2024Q4): management +0.57 vs analyst floor +0.00 → delta +0.57 (n=34 mgmt / 26 Q&A; 84th pctile across the S&P book, z +1.1).
Flag: ELEVATED — management unusually upbeat vs the analyst floor relative to peers (disconfirmation watch).
| Quarter | Mgmt | Analyst | Delta |
|---|---|---|---|
| 2024Q4 | +0.57 | +0.00 | +0.57 |
| 2024Q3 | +0.53 | +0.00 | +0.53 |
| 2024Q2 | +0.70 | — | — |
| 2024Q1 | +0.38 | — | — |
News (last 365d, 503 articles): avg ticker sentiment +0.15 (bullish 20% / bearish 2%)
Scenario Analysis
The tree runs from a structural 'Structural — Underwriting / Reserve / Catastrophe Reset' downside ($51) to a 'Bull — Re-Rate' bull case ($202); the probability-weighted blend (PWEV $112) is -5% versus spot.
| Scenario | Probability | Target | Return vs spot |
|---|---|---|---|
| Structural — Underwriting / Reserve / Catastrophe Reset | 20% | $51 | -56% |
| Soft Market / Investment Loss | 17% | $81 | -31% |
| Base — Mid-Cycle Combined Ratio | 35% | $114 | -3% |
| Growth — Hard Market / Pricing + Float Income | 20% | $158 | +35% |
| Bull — Re-Rate | 8% | $202 | +73% |
| Probability-Weighted (PWEV) | — | $112 | -5% |
Scenario rationale — what each probability buys (the driver path behind every target):
- Structural — Underwriting / Reserve / Catastrophe Reset (20%, $51). Structural impairment — underwriting / reserve / catastrophe reset: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 49.0; probability: 0.2.
- Soft Market / Investment Loss (17%, $81). Cyclical downturn — underwriting margin (combined ratio) + premium growth + float investment income + reserves weakens for 1–2 years before normalising. Drivers — implied_target: 83.21; probability: 0.17.
- Base — Mid-Cycle Combined Ratio (35%, $114). Mid-cycle — normalised underwriting margin (combined ratio) + premium growth + float investment income + reserves; disciplined capital allocation; steady returns. Drivers — implied_target: 115.57; probability: 0.35.
- Growth — Hard Market / Pricing + Float Income (20%, $158). Upside — hard market + pricing lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 156.02; probability: 0.2.
- Bull — Re-Rate (8%, $202). Upside tail — sustained tight conditions or a structural re-rate on hard market + pricing. Drivers — implied_target: 197.04; probability: 0.08.
Valuation Triangulation
Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.
| Method | Basis | Fair Value | vs Spot |
|---|---|---|---|
| Monte Carlo median (Student-t + regime) | multiple | $98 | -16% |
| Peer P/E re-rate | multiple | $91 | -22% |
| Peer EV/Revenue re-rate | multiple | $109 | -7% |
| Scenario PWEV | multiple | $112 | -5% |
| Justified P/B (ROE-based) | book value × ROE | $87 | -26% |
| Triangulated (weighted) | — | $96 | -18% |
Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.
Rating vs blend — the key debate. The rating tracks the multiple-discipline fair value (Monte Carlo $98 + scenario PWEV $112, ≈ spot); the weighted blend $96 (-18%) sits below it because the cash-flow DCF ($87) is materially more conservative than the market multiple. Whether the current multiple is justified is the central question for this name — and the principal downside risk to the rating.
Book Value, ROE & Capital Returns
For a bank or insurer the cash-flow DCF is the wrong intrinsic anchor — capital is the product. Value is set by return on equity vs cost of equity against book value: the Gordon-justified multiple is P/B = (ROE − g) / (COE − g).
| Metric | Value |
|---|---|
| Book value / share | $91 |
| Return on equity (ROE) | 9.2% |
| Cost of equity (assumed) | 9.5% |
| Current P/B | 1.29x |
| Justified P/B (ROE-based) | 0.95x |
| Justified value / share | $87 (-26%) |
ROE of 9.2% falls short of the ~10% cost of equity — which is why a modest justified P/B of 0.95x (vs 1.29x current) is warranted. The justified value sits -26% vs spot; that gap, plus the credit / underwriting cycle in the scenarios, is the debate. The Monte Carlo and scenario PWEV carry the earnings (P/E) view; this block carries the book-value view.
Monte Carlo — the distribution, not a point
10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $98 and 37% of paths finish above spot. The variance decomposition shows the gross margin is the dominant swing factor (60% of variance). The fundamental driver, not the multiple, sets the spread — a cleaner setup.
Peer benchmarking — relative value
Against the peer cohort, re-rating to the peer-median forward multiple (P/E 9.8x) implies $91. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 20% so the market's mood does not drive the fair value.
Across all anchors the spread is 26% of the median — moderate (healthy method disagreement — read the blend with care).
Revenue-Segment Breakdown
The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)
| Segment | Revenue | Mix | Growth | Op margin | EBIT | Multiple | Capex % | Tag |
|---|---|---|---|---|---|---|---|---|
| Insurance (Underwriting + Float) | $18.5B | 100% | 5% | 12% | $2.3B | 12x | 1% | ESTIMATE |
| EBIT = segment revenue × operating margin (segment EBITDA not shown — per-segment D&A is not separately disclosed). |
Named Exposures
Demand & pricing cycle (FACT/ESTIMATE)
| Dimension | Assessment |
|---|---|
| driver | underwriting margin (combined ratio) + premium growth + float investment income + reserves |
| net_debt_or_cash_b | -8.09 |
Capital intensity & shareholder returns (ESTIMATE)
| Dimension | Assessment |
|---|---|
| capex_pct_revenue | 0.01 |
| div_yield | 0.0022 |
Structural risk vs optionality (INFERENCE)
| Dimension | Assessment |
|---|---|
| downside | underwriting / reserve / catastrophe reset |
| upside | hard market + pricing |
Industry Context — Financials — Insurers
This name sits in the Financials — Insurers as a insurer. underwriting margin (combined ratio) + premium growth + float investment income + reserves Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.
Value chain: CB (insurer) · PGR (insurer) · TRV (insurer) · ALL (insurer) · AFL (insurer) · MET (insurer) · AIG (insurer) · PRU (insurer) · HIG (insurer) · ACGL (insurer) · CINF (insurer) · WRB (insurer) · PFG (insurer) · L (insurer) · EG (insurer) · GL (insurer) · AIZ (insurer)
| Shared state | Capex path | House view | This name implies |
|---|---|---|---|
| Underwriting / Reserve / Catastrophe Reset | 37% | 37% | |
| Mid-Cycle — Combined Ratio + Float | 35% | 35% | |
| Upside — Hard Market / Pricing | 28% | 28% |
Mapping note: name-level 'Structural — Underwriting / Reserve / Catastrophe Reset' (20%) + 'Soft Market / Investment Loss' (17%) map to cluster Underwriting / Reserve / Catastrophe Reset (37%); name-level 'Growth — Hard Market / Pricing + Float Income' (20%) + 'Bull — Re-Rate' (8%) map to cluster Upside — Hard Market / Pricing (28%) — the cluster row is the SUM of the mapped scenario probabilities, not a different estimate.
On the cluster's key downside — Underwriting / Reserve / Catastrophe Reset () — this name implies 37% vs the cluster house view of 37% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.
Structure: Shared State — The fin_insurers cycle is the shared macro driver. Driver — underwriting margin (combined ratio) + premium growth + float income + reserves Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).
Consensus & Market Expectations
| Reference | Value |
|---|---|
| Street target (mean) | $60 (-49% vs spot · street) |
| House target | $111 (+85.6% vs street) |
_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.
Balance Sheet & Liquidity
| Metric | Value |
|---|---|
| Net debt | $0.9B — modestly levered |
| Net debt / EBITDA | 0.29x |
| Interest coverage (EBIT / interest) | 6.2x |
| Current ratio | 0.48x |
| Cash & ST investments | $8.6B |
Balance-sheet data as of 2025-12-31 (Alpha Vantage).
Capital Allocation
| Metric | Value |
|---|---|
| Free cash flow | $2.7B |
| Buybacks / dividends | $0.8B / $0.1B |
| Total shareholder yield | 3.6% |
| Payout as % of FCF | 31.8% |
| Reinvestment (capex / OCF) | 17.7% |
| Allocation stance | balanced |
Free-Cash-Flow Quality
| Metric | Value |
|---|---|
| FCF margin | 14.6% |
| FCF conversion (FCF / net income) | 152.4% |
| FCF yield | 11.4% |
| Capex intensity (capex / revenue) | 3.1% |
| FCF − SBC (diagnostic) | $2.7B |
| Capex split (maint / growth) | 65% / 35% — Consolidated capex is dominated by Boardwalk pipeline maintenance and hotel refurbishment; insurance is capital-light. Growth spend funds pipeline expansions and hotel development. Skews to maintenance. |
Accounting quality: cash conversion (OCF/NI) 185% — cash-backed.
Catalyst Calendar
- 2026-02-10 (~-148d) — FY results & CNA special-dividend declaration (authored)
- 2026-05-12 (~-57d) — Annual buyback pace / NAV-discount update at AGM (authored)
- 2026-08-03 (~26d) — Quarterly earnings (AV EARNINGS_CALENDAR)
- 2027-01-15 (~191d) — Atlantic hurricane season loss-development / reserve review (authored)
Forecast Track Record
- EPS surprise: beat 50.0% of the last 4 quarters; average surprise -5.1%.
Competitive Moat
Narrow moat. Loews's moat is narrow and structural rather than franchise-based — it is a holding company whose value is CNA (P&C insurance), Boardwalk Pipelines, hotels and cash, with a persistent conglomerate/holdco discount; insurance underwriting has no durable moat (commodity risk transfer), so the terminal multiple is appropriately near book (~1.0-1.2x) and ~12x earnings, and only credible if the holdco discount narrows via buybacks — absent that, the sum-of-parts optionality does not justify a re-rate above book value.
Moat sources:
- Controlling stake in CNA Financial (~90%) — underwriting + float, but commodity insurance economics
- Boardwalk Pipelines (regulated gas transport) — contracted cash flow
- Loews Hotels portfolio and large net-cash holdco balance sheet
- Disciplined capital allocation / buyback history narrowing the NAV discount
Regulatory & Legal Risk
| Issue | Probability | Valuation sensitivity | Horizon |
|---|---|---|---|
| State insurance-regulator rate approvals and reserve-adequacy oversight at CNA | medium (~40%) | medium - rate-approval lag or reserve strengthening hits the largest sum-of-parts leg; ~6% of FV | 12-24m |
| FERC tariff/regulation on Boardwalk Pipelines and emissions rules | low (~25%) | low - smaller segment, largely contracted; ~2% of FV | 12-24m |
Probabilities and sensitivities are analyst estimates, not market-implied.
Scenario Macro & Key Risks
| Scenario | Macro assumption | Key risk |
|---|---|---|
| Structural — Underwriting / Reserve / Catastrophe Reset | A cycle of adverse reserve development, social inflation and elevated catastrophe losses permanently resets CNA's underwriting profitability. | Reserve strengthening at CNA impairs book value, widening the holdco discount just as the largest leg de-rates. |
| Soft Market / Investment Loss | P&C pricing softens (excess capital, competition) while a risk-asset drawdown hits CNA's investment portfolio and float income. | Combined ratio deteriorates as pricing falls at the same time investment income and float yields compress. |
| Base — Mid-Cycle Combined Ratio | Normal mid-cycle P&C conditions; combined ratio in the mid-90s, stable float income, steady holdco buybacks. | The conglomerate discount persists indefinitely, so intrinsic sum-of-parts value is never realised by shareholders. |
| Growth — Hard Market / Pricing + Float Income | Hard P&C market with rising rates lifts both underwriting margin and reinvestment yields on CNA's float. | Hard-market pricing gains attract capacity and revert; higher rates that boost float also mark down the bond portfolio. |
| Bull — Re-Rate | The market narrows the holdco/NAV discount as buybacks and sum-of-parts clarity re-rate the shares toward intrinsic value. | Discount re-rates are historically slow and reversible; a single catastrophe or reserve miss reopens the gap. |
What the Market Is Pricing In
Variant perception: the house view is above-consensus, and the thesis is primarily event-driven.
| Metric | Consensus | House | Importance |
|---|---|---|---|
| Revenue | — | 19.4 | High |
| EPS | 0.0 | 9.3 | Medium |
| Target price | 60.0 | 111.4 | Medium |
Peer Quality & Weighting
| Peer | Fwd P/E | Growth | Op margin | Quality | Weight cap |
|---|---|---|---|---|---|
| AIG | 9.3× | 5% | 19% | segment | 50% |
| AIZ | 10.21× | 5% | 11% | direct | 100% |
| PFG | 9.39× | 5% | 15% | segment | 50% |
| TROW | 11.05× | 6% | 37% | direct | 100% |
Quality-weighted forward P/E: 10.2× (simple median 9.8×). Direct peers count 100%, segment 50%, broad 25%.
Historical-range cross-check: 52-week range $89–$115, centre $101 (-14% vs spot); spot sits at the 108th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.
Risk / Reward & Margin of Safety
| Metric | Value |
|---|---|
| Upside to triangulated FV | $96 (-18% vs spot · triangulated FV) |
| Downside to bear case (Structural — Underwriting / Reserve / Catastrophe Reset) | $51 (-56% vs spot · bear scenario) |
| Reward/risk ratio | 0.3× |
| Margin of safety (FV vs spot) | -21% |
| P(price > spot) — Monte Carlo | 37% |
Reward/risk compares triangulated upside against the probability-weighted bear target, not the extreme tail. Bull case (Bull — Re-Rate): $202.
Assumption Register
| Assumption | Value | Used in | Source |
|---|---|---|---|
| SBC dilution | 0.0%/yr | PWEV, MC, DCF (charged once) | estimate (from SBC/rev) |
| EPS basis | consensus forward EPS (broker-adjusted, non-GAAP) | all forward P/E & scenario multiples | definition |
Inputs, Sources & Confidence
Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)
| Input | Value | Type | Source | Confidence | Used in |
|---|---|---|---|---|---|
| Revenue TTM | $18.5B | reported fact | 10-K/10-Q via AV | High | Forecast base, EV/Rev |
| FY+1 guided revenue | $19.4B | company guidance | Company guidance | Medium | Forecast, SoP |
| Diluted shares | 0.202B | reported fact | 10-K via AV | High | Market cap, per-share |
| Net debt / cash | $0.928B | reported fact | Balance sheet via AV | High | EV, DCF equity bridge |
Source Log
| Source | Type | Date | Used for | Reference |
|---|---|---|---|---|
| Alpha Vantage — GLOBAL_QUOTE / OVERVIEW | market data | 2026-07-08 | Price, market cap, EV, 52-week range, forward P/E | Alpha Vantage 2026-06-27 |
| Company income statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-07-08 | Revenue, gross/operating margin, EBIT, interest expense | INCOME_STATEMENT / latest annual |
| Company balance sheet (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-07-08 | Cash, debt, net debt, leases, equity, coverage | BALANCE_SHEET / latest annual |
| Company cash-flow statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-07-08 | Operating cash flow, capex, FCF, buybacks, dividends, SBC | CASH_FLOW / latest annual |
| Company earnings releases via Alpha Vantage | reported fact | 2026-07-08 | Reported EPS, surprise history | EARNINGS / quarterly |
| Sell-side consensus via Alpha Vantage | consensus estimate | 2026-07-08 | Forward revenue/EPS consensus, analyst count | EARNINGS_ESTIMATES |
| Earnings calendar via Alpha Vantage | market data | 2026-07-08 | Next earnings date, catalyst timing | EARNINGS_CALENDAR |
| Company guidance | company guidance | 2026-07-08 | FY guided revenue / non-GAAP EPS basis | company guidance / earnings call |
| MCH segment model (from filings & disclosures) | house estimate | 2026-07-08 | Segment revenue, margins, multiples, AI decomposition | company_context (authored, tagged) |
| MCH qualitative analysis | inference | 2026-07-08 | Moat, regulatory risk, scenario macro, catalysts | company_context enrichment (authored) |
| MCH investment thesis & falsification triggers | house estimate | 2026-07-08 | Thesis, anti-thesis, thesis-break signals | authored §5.3 |
Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.
Load-Bearing Assumptions
No DCF anchor is meaningful for this asset; the blend leans 50% on probability-weighted scenarios and 30% on the Monte Carlo median — the scenario probabilities are the load-bearing inputs.
Reasons the Thesis Could Fail (Falsifiable)
Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:
- CNA net combined ratio > 99.0 (2 consecutive prints → Underwriting / Reserve / Catastrophe Reset). Sits between the mid-cycle base (mid-90s) and the soft-market/reset path. A print above 99 two quarters running signals the underwriting margin has moved from the base toward the adjacent-bear driver.
- Prior-year reserve development < 0.0 (2 consecutive prints → Underwriting / Reserve / Catastrophe Reset). Loews earnings lean on favourable reserve releases. Two quarters of adverse (unfavourable) development would confirm the reserve-adequacy risk central to the structural path.
- Net investment income (float) year-on-year change < -0.05 (2 consecutive prints → Mid-Cycle — Combined Ratio + Float). A decline of more than 5% year-on-year for two quarters would mark the soft-market/investment-loss driver, in which float income no longer supports mid-cycle earnings.
- Net premiums written growth < 0.0 (2 consecutive prints → Underwriting / Reserve / Catastrophe Reset). The base path assumes low-single-digit premium growth. Two quarters of contracting premiums written would indicate rate adequacy and volume are both slipping, consistent with the soft-market driver rather than mid-cycle.
- Consolidated book value per share year-on-year change < -0.08 (2 consecutive prints → Underwriting / Reserve / Catastrophe Reset). Book value per share is $90.9. A fall of more than 8% year-on-year over two prints, absent a discrete distribution, would flag underwriting or investment-portfolio impairment feeding the structural reset.
Fact / Inference / Speculation
- FACT: Spot $117; 52-week range $89–$115; engine rating HOLD; base-case target $111 (-5%). (source: Alpha Vantage 2026-06-27, 8 July 2026)
- INFERENCE: Triangulated FV $96 (-18% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits below the multiple-discipline core.
- SPECULATION: At current prices the embedded bet is that Gross Margin keeps surprising favourably — an operating call the next two prints will test.
Recommendation: HOLD
Balanced: triangulated fair value $103 (-12% vs spot); the outcome hinges on Gross Margin. The debate is Gross Margin — a fundamental call.
Disclosures & Limitations
This report is for informational and research purposes only. It is not personalised investment advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.
- No suitability assessment has been performed for any individual.
- Market data may be delayed or inaccurate; figures are as of the analysis date.
- Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
- Forecasts are uncertain; past performance is not indicative of future returns.
- The author or publisher may hold positions in securities mentioned.
- Users should verify information against primary sources (company filings) before acting.
- Investing involves risk of loss; there is no guarantee any target price is achieved.
- Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.